Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > It's time for a takout

<< Previous

Bullboard Posts

Next >>

Comment by Momo25on Jul 26, 2023 9:15am

125 Views

Post# 35557397

RE:RE:RE:RE:RE:RE:RE:RE:It's time for a takout

I guess your post is a response to mine. I don't need any advise from you or from anyone else. I was directing my comment to a guy (Speceo) who used to defend fiercely the TH strategy because, as all of know, he hold few millions of shares as a small investor fund . I know pretty well what I do with my shares and I am not influenced by him at all. I am just exhausted to hear the same song from him that is not pleasant to ears.

<< Previous

Bullboard Posts

Next >>

Transportation technology stock secures second major contract in a week